Microsoft co-founder pledges $300m to brain research

By Admin
The co-founder of Microsoft, Paul Allen, has promised to donate £300 million of his personal fortune into brain research. He is planning to inves...

The co-founder of Microsoft, Paul Allen, has promised to donate £300 million of his personal fortune into brain research.

He is planning to invest the money into the organisation he set up, the Allen Institute for Brain Science, over the next three years.

Allen has said the money will go towards understanding how the brain works, an investigation which will have three main research initiatives.   

The project is expected to take 10 years to complete and the $300 million donation means Allen’s personal donations to the Institute now total $500 million.  

To read the latest edition of Healthcare Global, click here

The three following questions will form the basis of the research:

  • How does the brain store, encode and process information?
  • What are the cellular building blocks that underlie all brain function, and are often targets of disease?
  • How do those cells develop, and then create the circuits that drive behavior, thought and brain dysfunction?

To carry out such an in-depth investigation, there are plans to double the current employee compliment to 350 over the next four years, and hiring has already begun.  

Alan has charged the Institute with tackling some of the most fundamental and complex questions in brain science today.

The answers to such questions are essential for achieving a complete understanding of how the brain works, what goes wrong in brain-related diseases and disorders, and how best to treat them.

Commenting on the donation, Allen said: “The accomplishments of the Institute have been truly remarkable.

“With its disciplined, mission-focused approach, the Institute has successfully tackled big-science projects, delivering tangible results that are helping to advance brain research around the world every day.”

“I am excited to expand the scale and scope of the Institute's efforts, and I look forward to seeing what we will accomplish in the future,” he added.

Meanwhile Allan Jones, CEO of the Allen Institute for Brain Science, said: “Paul Allen's generosity and bold vision have allowed us to build a unique organisation and advance brain research in ways that wouldn't be possible otherwise.

“This new funding enables us to apply our structured, industrial-scale approach to science to tackle increasingly complex questions about how the brain works—questions that must be answered if we are to understand and treat autism, Alzheimer's disease, depression, traumatic brain injury and the myriad other brain-related diseases and disorders that affect all of us either directly or indirectly.”

The Healthcare Global magazine is now available on the iPad. Click here to download it.


Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI


Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI